Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future.

Prevalence rates for diabetes mellitus continue to rise, which, coupled with increasing costs of complications, has appreciably increased expenditure in recent years. Poor glycaemic control includi...